Skip to main content
Smart Investors Daily
TC

NASDAQ · TCMD

Tactile Systems Technology, Inc.

Healthcare · Medical - Devices

$22.87

Up+$1.91 (+8.35%)

Updated Nov 4, 2026, 12:45 AM

SID Score

4.8/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
630.31M
P/E ratio
43.12
Dividend yield
0.00%
52-week range
$14.84 – $37.77
Volume
245.73K
Avg. volume
371.72K

Price performance · TCMD

TCMD price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Nov 2, 2026

TCMD closed at $22.87 after 20 trading sessions, up 3.06% for the selected period.

Last close
$22.87
Period change
+3.06%
Period low
$22.02
Period high
$24.31
Daily close
View OHLC price history
TCMD OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 2, 2026$23.49$23.84$22.726$22.87245.73K
Oct 30, 2026$24.32$24.345$22.85$23.04210.71K
Oct 29, 2026$24.11$24.58$24.11$24.31157.91K
Oct 28, 2026$23.38$24.08$23.38$23.91140.11K
Oct 27, 2026$23.43$23.53$23.225$23.46188.66K
Oct 26, 2026$23.73$23.905$23.36$23.39162.48K
Oct 23, 2026$23.56$23.84$23.48$23.64130.82K
Oct 22, 2026$23.21$23.87$23.21$23.54134.59K
Oct 21, 2026$23.34$23.86$23.12$23.28148.92K
Oct 20, 2026$22.84$23.68$22.84$23.52215.34K
Oct 19, 2026$22.53$22.845$22.45$22.73165.22K
Oct 16, 2026$23.31$23.41$22.48$22.52214.53K
Oct 15, 2026$22.64$23.35$22.5893$23.29211.41K
Oct 14, 2026$22.11$22.47$22.025$22.41159.77K
Oct 13, 2026$22.66$22.96$22.24$22.31155.1K
Oct 12, 2026$22.28$22.67$22.28$22.62178.23K
Oct 9, 2026$22.06$22.51$22.00$22.44136.72K
Oct 8, 2026$22.17$22.315$21.66$22.12368.81K
Oct 7, 2026$22.01$22.43$21.83$22.02215.98K
Oct 6, 2026$22.52$22.69$21.92$22.19148.58K

Latest TCMD news

The latest Smart Investors Daily articles mentioning TCMD.

TCMD research

Overview

Company profile and research snapshot.

Company profile

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$26.67
Implied upside
—
Analysts
11
TCMD recent ratings
DateFirmRatingTarget
Nov 3, 2026BTIGBuy—
Oct 12, 2026BTIGBuy—
Aug 11, 2026BTIGBuy—
May 21, 2026BTIGBuy—
May 7, 2026B. Riley SecuritiesBuy—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.